LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

PRORP domain-containing protein

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
PRORP domain-containing protein
Gene product:
hypothetical protein, conserved
Species:
Leishmania braziliensis
UniProt:
A4HNH1_LEIBR
TriTrypDb:
LbrM.34.5030 , LBRM2903_340060800 *
Length:
581

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. yes yes: 5
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 16
NetGPI no yes: 0, no: 16
Cellular components
Term Name Level Count
GO:0005739 mitochondrion 5 12
GO:0043226 organelle 2 16
GO:0043227 membrane-bounded organelle 3 16
GO:0043229 intracellular organelle 3 16
GO:0043231 intracellular membrane-bounded organelle 4 16
GO:0110165 cellular anatomical entity 1 16

Expansion

Sequence features

A4HNH1
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: A4HNH1

Function

Biological processes
Term Name Level Count
GO:0006139 nucleobase-containing compound metabolic process 3 16
GO:0006396 RNA processing 6 16
GO:0006399 tRNA metabolic process 7 16
GO:0006725 cellular aromatic compound metabolic process 3 16
GO:0006807 nitrogen compound metabolic process 2 16
GO:0008033 tRNA processing 8 16
GO:0008152 metabolic process 1 16
GO:0009987 cellular process 1 16
GO:0016070 RNA metabolic process 5 16
GO:0034470 ncRNA processing 7 16
GO:0034641 cellular nitrogen compound metabolic process 3 16
GO:0034660 ncRNA metabolic process 6 16
GO:0043170 macromolecule metabolic process 3 16
GO:0044237 cellular metabolic process 2 16
GO:0044238 primary metabolic process 2 16
GO:0046483 heterocycle metabolic process 3 16
GO:0071704 organic substance metabolic process 2 16
GO:0090304 nucleic acid metabolic process 4 16
GO:1901360 organic cyclic compound metabolic process 3 16
GO:0000966 RNA 5'-end processing 7 1
GO:0001682 tRNA 5'-leader removal 9 1
GO:0099116 tRNA 5'-end processing 8 1
Molecular functions
Term Name Level Count
GO:0003824 catalytic activity 1 16
GO:0016787 hydrolase activity 2 16
GO:0004518 nuclease activity 4 6
GO:0004519 endonuclease activity 5 5
GO:0004521 RNA endonuclease activity 5 5
GO:0004526 ribonuclease P activity 6 5
GO:0004540 RNA nuclease activity 4 5
GO:0004549 tRNA-specific ribonuclease activity 5 5
GO:0016788 hydrolase activity, acting on ester bonds 3 6
GO:0016891 RNA endonuclease activity, producing 5'-phosphomonoesters 6 5
GO:0016893 endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters 6 5
GO:0140098 catalytic activity, acting on RNA 3 5
GO:0140101 catalytic activity, acting on a tRNA 4 5
GO:0140640 catalytic activity, acting on a nucleic acid 2 5

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 347 351 PF00656 0.476
CLV_C14_Caspase3-7 365 369 PF00656 0.494
CLV_C14_Caspase3-7 464 468 PF00656 0.450
CLV_NRD_NRD_1 161 163 PF00675 0.440
CLV_NRD_NRD_1 174 176 PF00675 0.300
CLV_NRD_NRD_1 51 53 PF00675 0.377
CLV_PCSK_KEX2_1 15 17 PF00082 0.677
CLV_PCSK_KEX2_1 161 163 PF00082 0.432
CLV_PCSK_KEX2_1 173 175 PF00082 0.331
CLV_PCSK_KEX2_1 51 53 PF00082 0.396
CLV_PCSK_PC1ET2_1 15 17 PF00082 0.768
CLV_PCSK_PC1ET2_1 173 175 PF00082 0.408
CLV_PCSK_PC7_1 47 53 PF00082 0.513
CLV_PCSK_SKI1_1 12 16 PF00082 0.544
CLV_PCSK_SKI1_1 161 165 PF00082 0.425
CLV_PCSK_SKI1_1 174 178 PF00082 0.272
CLV_PCSK_SKI1_1 213 217 PF00082 0.412
CLV_PCSK_SKI1_1 260 264 PF00082 0.496
CLV_PCSK_SKI1_1 293 297 PF00082 0.489
CLV_PCSK_SKI1_1 303 307 PF00082 0.456
CLV_PCSK_SKI1_1 487 491 PF00082 0.314
CLV_PCSK_SKI1_1 55 59 PF00082 0.466
CLV_Separin_Metazoa 92 96 PF03568 0.518
DEG_APCC_DBOX_1 160 168 PF00400 0.354
DOC_CKS1_1 106 111 PF01111 0.368
DOC_CKS1_1 427 432 PF01111 0.260
DOC_CYCLIN_RxL_1 257 266 PF00134 0.488
DOC_MAPK_DCC_7 386 395 PF00069 0.566
DOC_MAPK_gen_1 173 182 PF00069 0.423
DOC_MAPK_gen_1 411 420 PF00069 0.304
DOC_MAPK_gen_1 506 515 PF00069 0.438
DOC_MAPK_MEF2A_6 140 148 PF00069 0.342
DOC_MAPK_MEF2A_6 509 517 PF00069 0.459
DOC_MAPK_MEF2A_6 75 82 PF00069 0.531
DOC_PP4_FxxP_1 387 390 PF00568 0.591
DOC_SPAK_OSR1_1 386 390 PF12202 0.587
DOC_USP7_MATH_1 118 122 PF00917 0.339
DOC_USP7_MATH_1 149 153 PF00917 0.375
DOC_USP7_MATH_1 188 192 PF00917 0.256
DOC_USP7_MATH_1 366 370 PF00917 0.297
DOC_USP7_MATH_1 94 98 PF00917 0.292
DOC_WW_Pin1_4 1 6 PF00397 0.535
DOC_WW_Pin1_4 105 110 PF00397 0.485
DOC_WW_Pin1_4 265 270 PF00397 0.497
DOC_WW_Pin1_4 286 291 PF00397 0.628
DOC_WW_Pin1_4 426 431 PF00397 0.353
DOC_WW_Pin1_4 445 450 PF00397 0.366
LIG_14-3-3_CanoR_1 236 240 PF00244 0.571
LIG_14-3-3_CanoR_1 495 501 PF00244 0.375
LIG_14-3-3_CanoR_1 509 514 PF00244 0.330
LIG_14-3-3_CanoR_1 519 524 PF00244 0.317
LIG_14-3-3_CterR_2 579 581 PF00244 0.380
LIG_Actin_WH2_2 134 149 PF00022 0.445
LIG_BIR_II_1 1 5 PF00653 0.664
LIG_BIR_III_2 165 169 PF00653 0.481
LIG_BIR_III_2 20 24 PF00653 0.421
LIG_BIR_III_4 63 67 PF00653 0.384
LIG_BRCT_BRCA1_1 190 194 PF00533 0.381
LIG_BRCT_BRCA1_1 383 387 PF00533 0.651
LIG_BRCT_BRCA1_1 447 451 PF00533 0.409
LIG_Clathr_ClatBox_1 37 41 PF01394 0.321
LIG_CtBP_PxDLS_1 22 26 PF00389 0.380
LIG_deltaCOP1_diTrp_1 573 578 PF00928 0.401
LIG_EVH1_1 446 450 PF00568 0.220
LIG_FHA_1 106 112 PF00498 0.571
LIG_FHA_1 200 206 PF00498 0.407
LIG_FHA_1 235 241 PF00498 0.509
LIG_FHA_1 414 420 PF00498 0.350
LIG_FHA_1 570 576 PF00498 0.493
LIG_FHA_2 227 233 PF00498 0.398
LIG_FHA_2 345 351 PF00498 0.405
LIG_FHA_2 462 468 PF00498 0.359
LIG_GBD_Chelix_1 296 304 PF00786 0.385
LIG_LIR_Apic_2 384 390 PF02991 0.595
LIG_LIR_Gen_1 191 200 PF02991 0.552
LIG_LIR_Gen_1 332 340 PF02991 0.405
LIG_LIR_Gen_1 342 352 PF02991 0.381
LIG_LIR_Gen_1 454 463 PF02991 0.315
LIG_LIR_Nem_3 191 197 PF02991 0.473
LIG_LIR_Nem_3 209 215 PF02991 0.396
LIG_LIR_Nem_3 332 336 PF02991 0.436
LIG_LIR_Nem_3 342 348 PF02991 0.431
LIG_LIR_Nem_3 454 459 PF02991 0.361
LIG_LIR_Nem_3 478 484 PF02991 0.355
LIG_LIR_Nem_3 499 503 PF02991 0.352
LIG_MAD2 101 109 PF02301 0.354
LIG_Pex14_1 208 212 PF04695 0.361
LIG_Pex14_1 536 540 PF04695 0.452
LIG_Pex14_2 133 137 PF04695 0.510
LIG_Pex14_2 177 181 PF04695 0.344
LIG_Pex14_2 387 391 PF04695 0.615
LIG_Pex14_2 488 492 PF04695 0.350
LIG_PTB_Apo_2 175 182 PF02174 0.252
LIG_PTB_Apo_2 450 457 PF02174 0.338
LIG_PTB_Apo_2 56 63 PF02174 0.374
LIG_PTB_Phospho_1 450 456 PF10480 0.338
LIG_REV1ctd_RIR_1 486 495 PF16727 0.350
LIG_SH2_CRK 345 349 PF00017 0.397
LIG_SH2_CRK 460 464 PF00017 0.348
LIG_SH2_SRC 363 366 PF00017 0.344
LIG_SH2_STAP1 345 349 PF00017 0.377
LIG_SH2_STAP1 435 439 PF00017 0.293
LIG_SH2_STAP1 521 525 PF00017 0.352
LIG_SH2_STAT5 183 186 PF00017 0.391
LIG_SH2_STAT5 456 459 PF00017 0.336
LIG_SH2_STAT5 480 483 PF00017 0.410
LIG_SH2_STAT5 516 519 PF00017 0.226
LIG_SH2_STAT5 540 543 PF00017 0.459
LIG_SH3_1 16 22 PF00018 0.516
LIG_SH3_3 16 22 PF00018 0.513
LIG_SH3_3 173 179 PF00018 0.458
LIG_SH3_3 386 392 PF00018 0.457
LIG_SH3_3 444 450 PF00018 0.220
LIG_SH3_3 480 486 PF00018 0.505
LIG_SH3_4 306 313 PF00018 0.431
LIG_SUMO_SIM_anti_2 416 421 PF11976 0.220
LIG_SUMO_SIM_anti_2 542 548 PF11976 0.537
LIG_SUMO_SIM_par_1 36 41 PF11976 0.321
LIG_TRFH_1 286 290 PF08558 0.361
LIG_TYR_ITIM 354 359 PF00017 0.378
LIG_WRC_WIRS_1 283 288 PF05994 0.423
MOD_CDC14_SPxK_1 4 7 PF00782 0.533
MOD_CDK_SPxK_1 1 7 PF00069 0.535
MOD_CDK_SPxxK_3 286 293 PF00069 0.361
MOD_CK1_1 268 274 PF00069 0.434
MOD_CK1_1 344 350 PF00069 0.578
MOD_CK1_1 380 386 PF00069 0.625
MOD_CK1_1 97 103 PF00069 0.354
MOD_CK2_1 226 232 PF00069 0.409
MOD_CK2_1 28 34 PF00069 0.395
MOD_CK2_1 310 316 PF00069 0.502
MOD_CK2_1 397 403 PF00069 0.456
MOD_CK2_1 71 77 PF00069 0.529
MOD_Cter_Amidation 412 415 PF01082 0.350
MOD_GlcNHglycan 113 116 PF01048 0.497
MOD_GlcNHglycan 169 172 PF01048 0.571
MOD_GlcNHglycan 24 28 PF01048 0.572
MOD_GlcNHglycan 441 445 PF01048 0.306
MOD_GSK3_1 23 30 PF00069 0.586
MOD_GSK3_1 282 289 PF00069 0.439
MOD_GSK3_1 366 373 PF00069 0.561
MOD_GSK3_1 376 383 PF00069 0.660
MOD_GSK3_1 461 468 PF00069 0.372
MOD_GSK3_1 504 511 PF00069 0.250
MOD_GSK3_1 553 560 PF00069 0.621
MOD_GSK3_1 574 581 PF00069 0.391
MOD_GSK3_1 93 100 PF00069 0.382
MOD_N-GLC_1 124 129 PF02516 0.291
MOD_N-GLC_1 431 436 PF02516 0.360
MOD_N-GLC_1 504 509 PF02516 0.440
MOD_N-GLC_1 551 556 PF02516 0.693
MOD_N-GLC_1 557 562 PF02516 0.691
MOD_NEK2_1 111 116 PF00069 0.507
MOD_NEK2_1 199 204 PF00069 0.387
MOD_NEK2_1 263 268 PF00069 0.560
MOD_NEK2_1 370 375 PF00069 0.500
MOD_PIKK_1 529 535 PF00454 0.491
MOD_PK_1 519 525 PF00069 0.375
MOD_PKA_2 235 241 PF00069 0.292
MOD_PKA_2 496 502 PF00069 0.399
MOD_PKA_2 508 514 PF00069 0.357
MOD_PKA_2 94 100 PF00069 0.342
MOD_PKB_1 438 446 PF00069 0.220
MOD_Plk_1 188 194 PF00069 0.287
MOD_Plk_1 234 240 PF00069 0.443
MOD_Plk_1 27 33 PF00069 0.348
MOD_Plk_1 431 437 PF00069 0.429
MOD_Plk_1 440 446 PF00069 0.326
MOD_Plk_1 551 557 PF00069 0.721
MOD_Plk_2-3 28 34 PF00069 0.484
MOD_Plk_2-3 341 347 PF00069 0.399
MOD_Plk_4 118 124 PF00069 0.476
MOD_Plk_4 150 156 PF00069 0.520
MOD_Plk_4 235 241 PF00069 0.375
MOD_Plk_4 344 350 PF00069 0.434
MOD_Plk_4 358 364 PF00069 0.374
MOD_Plk_4 366 372 PF00069 0.424
MOD_Plk_4 413 419 PF00069 0.355
MOD_Plk_4 519 525 PF00069 0.343
MOD_Plk_4 78 84 PF00069 0.377
MOD_Plk_4 94 100 PF00069 0.298
MOD_ProDKin_1 1 7 PF00069 0.535
MOD_ProDKin_1 105 111 PF00069 0.478
MOD_ProDKin_1 265 271 PF00069 0.497
MOD_ProDKin_1 286 292 PF00069 0.626
MOD_ProDKin_1 426 432 PF00069 0.353
MOD_ProDKin_1 445 451 PF00069 0.366
MOD_SUMO_rev_2 206 215 PF00179 0.403
MOD_SUMO_rev_2 28 38 PF00179 0.363
MOD_SUMO_rev_2 332 339 PF00179 0.440
MOD_SUMO_rev_2 360 369 PF00179 0.445
TRG_DiLeu_BaEn_1 235 240 PF01217 0.385
TRG_DiLeu_BaEn_1 34 39 PF01217 0.539
TRG_ENDOCYTIC_2 212 215 PF00928 0.364
TRG_ENDOCYTIC_2 345 348 PF00928 0.391
TRG_ENDOCYTIC_2 356 359 PF00928 0.384
TRG_ENDOCYTIC_2 456 459 PF00928 0.346
TRG_ENDOCYTIC_2 460 463 PF00928 0.355
TRG_ENDOCYTIC_2 480 483 PF00928 0.410
TRG_ENDOCYTIC_2 500 503 PF00928 0.197
TRG_ER_diArg_1 16 19 PF00400 0.626
TRG_ER_diArg_1 160 162 PF00400 0.435
TRG_ER_diArg_1 174 176 PF00400 0.348
TRG_ER_diArg_1 371 374 PF00400 0.503
TRG_ER_diArg_1 492 495 PF00400 0.326
TRG_NLS_Bipartite_1 161 177 PF00514 0.518
TRG_NLS_MonoCore_2 14 19 PF00514 0.620
TRG_NLS_MonoExtC_3 14 19 PF00514 0.759
TRG_NLS_MonoExtN_4 12 19 PF00514 0.765
TRG_Pf-PMV_PEXEL_1 161 165 PF00026 0.500
TRG_Pf-PMV_PEXEL_1 423 427 PF00026 0.260

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1I198 Leptomonas seymouri 65% 98%
A0A0S4JLM5 Bodo saltans 39% 100%
A0A1X0P3X4 Trypanosomatidae 32% 100%
A0A1X0P680 Trypanosomatidae 41% 100%
A0A3Q8IIJ5 Leishmania donovani 80% 99%
A0A3R7LTW4 Trypanosoma rangeli 45% 100%
A0A422MWI6 Trypanosoma rangeli 31% 100%
A4HLQ7 Leishmania braziliensis 30% 82%
A4IC62 Leishmania infantum 81% 99%
C9ZYE1 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 43% 100%
D0A6B5 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 30% 100%
E9AFY2 Leishmania major 82% 100%
E9B735 Leishmania mexicana (strain MHOM/GT/2001/U1103) 80% 99%
V5B8T9 Trypanosoma cruzi 44% 100%
V5BPA7 Trypanosoma cruzi 29% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS